GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year PAT Growth History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| PAT Growth(%) | -19.14 | - |
What is the latest PAT Growth ratio of GUFIC BIOSCIENCES ?
| Year | PAT Growth |
|---|---|
| Mar2025 | -19.14 |
| Mar2024 | - |
How is PAT Growth of GUFIC BIOSCIENCES Trending?
| Years | PAT Growth | % Change | |
|---|---|---|---|
| Mar2025 | -19.14 | 0 | |
| Mar2024 | 0 | - | |
Other Financial Ratios of GUFIC BIOSCIENCES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare PAT Growth ratio of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹2,776.8 Cr | -0.7% | -10.4% | -15% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | -0.7% |
-10.4% |
-15% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses